REGENXBIO Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
REGENXBIO Inc. (RGNX) had Lessee, Operating Lease, Liability, to be Paid, Year One of $12.24 million as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-03-05
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $12.24M.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $12.35M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $11.94M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $11.33M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-12-31 | $12.24M 10-K · filed 2026-03-05 |
| 2024-12-31 | $12.35M 10-K · filed 2025-03-13 |
| 2023-12-31 | $11.94M 10-K · filed 2024-02-27 |
| 2022-12-31 | $11.33M 10-K · filed 2023-02-28 |
| 2021-12-31 | $6.56M 10-K · filed 2022-03-01 |
| 2020-12-31 | $4.16M 10-K · filed 2021-03-01 |
| 2020-09-30 | $1.12M 10-Q · filed 2020-11-04 |
| 2019-12-31 | $2.94M 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |